GlassScriptPhysician profile
Kevin Wall
NPI 1376003350
$41,510.77
in general payments reported to CMS, 2019-2025
9 companies · $11K in 2025
The $11K reported for 2025 was more than what 88% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $306 · 2024: $30K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $40K · Food and Beverage: $1,511.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $40,000.00 |
| Food and Beverage | $1,510.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $20,202.03 | 2024-2025 | Evos, Maverick, Redapt |
| Arthrex, INC. | $20,000.00 | 2024 | |
| Stryker Corporation | $419.19 | 2024-2025 | Blueprint Patient Specific Instrumentation, Aequalis Perform, Aequalis Perform+ |
| Exactech, INC. | $192.44 | 2025 | |
| Fortis Surgical, LLC | $171.14 | 2025 | |
| Zimmer Biomet Holdings, INC. | $165.60 | 2023-2024 | Identity, Tapestry |
| Medtronic, INC. | $155.38 | 2023-2025 | Interstim |
| Baxter Healthcare | $115.38 | 2025 | Floseal |
| Prime Surgical, LLC | $89.61 | 2023-2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Wall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.